Plaintiffs File Request for Multidistrict Litigation (MDL) in Farxiga Cases
In early February, plaintiffs in product liability cases involving the drug Farxiga (dapagliflozin) requested that all cases filed with federal court system over the side effects of the drug be moved to multidistrict litigation (MDL) in the U.S. District Court of the Eastern District of Pennsylvania.... Read More